Cotización Avenue Therapeutics - ATXI

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

2.01

Postura de Compra

2.01

Postura de Venta

2.31

Volume Operado de la Acción

0.00 Rango del Día 0.00

1.60 Rango de 52 semanas 26.4675

Capitalización de Mercado [m]

2.877M

Precio Anterior

2.01

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

45,910

Acciones en circulación

1,431,356

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.28

Beneficio por acción (BPA)

-7.25

turnover

Beneficio neto

-10.38M

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.avenuetx.com

Sede

Dover, Delaware, USA

Fundado

Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXI. The last closing price for Avenue Therapeutics was US$2.01. Over the last year, Avenue Therapeutics shares have traded in a share price range of US$ 1.60 to US$ 26.4675.

Avenue Therapeutics currently has 1,431,356 shares in issue. The market capitalisation of Avenue Therapeutics is US$2.88 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -0.28.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.06	3.07692307692	1.95	2.06	1.6	34605	1.93626125	CS
4	-0.13	-6.07476635514	2.14	2.63	1.6	51608	2.23095262	CS
12	-0.5201	-20.5564997431	2.5301	3.54	1.6	45910	2.24038054	CS
26	-1.86	-48.0620155039	3.87	3.9899	1.6	44447	2.70191159	CS
52	-13.065	-86.6666666667	15.075	26.4675	1.6	1973595	17.11888208	CS
156	-1392.99	-99.8559139785	1395	2013.75	1.6	1797302	341.8651411	CS
260	-6421.74	-99.9687098657	6423.75	14130	1.6	1146781	710.49741879	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
WORXSCWorx Corporation	US$ 2.03 (107.14%)	15.65M
PETWag Group Company	US$ 0.316 (50.40%)	17.62M
AKTSAkoustis Technologies Inc	US$ 0.1251 (43.63%)	55.43M
ESGROEnstar Group Ltd	US$ 28.00 (40.92%)	28
CCECCapital Clean Energy Carriers Corporation	US$ 24.99 (34.72%)	9
WSBFWaterstone Financial Inc	US$ 9.00 (-40.98%)	4
TRSTriMas Corporation	US$ 15.62 (-40.79%)	3
BCAXBicara Therapeutics Inc	US$ 11.00 (-40.15%)	212
PYXSPyxis Oncology Inc	US$ 2.40 (-37.17%)	208.06k
XNCRXencor Inc	US$ 15.11 (-36.30%)	2
AKTSAkoustis Technologies Inc	US$ 0.1251 (43.63%)	55.43M
PETWag Group Company	US$ 0.316 (50.40%)	17.62M
WORXSCWorx Corporation	US$ 2.03 (107.14%)	15.65M
XTKGX3 Holdings Company Ltd	US$ 0.073 (-18.89%)	10.75M
CRKNCrown Electrokinetics Corporation	US$ 1.00 (27.28%)	5.39M